• Founded: 2014
  • Location: San Francisco, CA
  • Employee range: 11 - 50
  • Funding: $45M B Feb 2021; $2.3M Apr 2015
  • Investors: SR One, Advent Life Sciences, Oxford Science Enterprises, OrbiMed, Monograph Capital



job board

Short description:

MicroRNA based diagnostic

Drug notes:

Contact us to add description: recruit@workinbiotech.com

Long description:

Miroculus is using microfluidics to automate and miniaturize genomic protocols. Next generation sequencing (NGS) is now commonplace in research labs, but it is still costly, time-consuming and requires expertise in sample preparation to achieve high-quality results. Miroculus’ digital microfluidic system enables full walkaway automation of complex sample preparation protocols. Beyond NGS, Miroculus’ technology can automate synthetic biology, cell editing and combinatorial chemistry. The benchtop instrument uses innovative single-use cartridges that are compatible with many reagents and solvents, with development in scaling this further. With these technologies, Miroculus is working to make the most complex protocols easy and accessible to scientists everywhere.


© 2024 Work In Biotech LLC
Personal data

Terms of Service

Privacy Policy

Contact: recruit@workinbiotech.com